CD8A and ovarian cancer: A study by Lee et al. suggests that during the early course of the disease, patients with germline BRCA1 and BRCA2 mutation-associated (gBRCA) ovarian cancer may have less circulating myeloid-derived suppressor cells (MDSCs) but more CD8+ T cells in the peripheral blood.